G
Gerold Meinhardt
Researcher at Bayer HealthCare Pharmaceuticals
Publications - 65
Citations - 7918
Gerold Meinhardt is an academic researcher from Bayer HealthCare Pharmaceuticals. The author has contributed to research in topics: Sorafenib & Hepatocellular carcinoma. The author has an hindex of 21, co-authored 61 publications receiving 5771 citations. Previous affiliations of Gerold Meinhardt include Bayer Corporation & Schering AG.
Papers
More filters
Journal ArticleDOI
Breast cancer, early stage
Tony Mok,L. Paz-Ares,Y-L. Wu,Silvia Novello,E. Juhasz,O. Aren,Yang Sun,Vera Hirsh,Egbert F. Smit,Chetan Lathia,T.J. Ong,Carol Peña,X. Pivot,G. Romieu,H. Bonnefoi,J-Y Pierga,P. Kerbrat,J-P. Guastalla,A. Lortholary,M. Espié,P. Fumoleau,D. Serin,J-P. Jacquin,C. Jouannaud,M. Rios,S. Abadie-Lacourtoisie,Nicole Tubiana-Mathieu,L. Cany,S. Catala,D. Khayat,I. Pauporte,A. Kramar,A. Goldhirsch,Martine Piccart,M. Procter,E. de Azambuja,Harald A. Weber,M. Untch,I.E. Smith,Luca Gianni,C. Jackisch,D. Cameron,Richard Bell,Mitchell Dowsett,R. D. Gelber,B. Leyland-Jones,José Baselga,Michael Baum,Jayant S. Vaidya,Max Bulsara,Frederik Wenz,Jeffrey S Tobias,W. Eiermann,D. Joseph,D. Joseph,Jean-Yves Pierga,Bernard Asselain,Samar Alsafadi,Etienne Brain,Florence Lerebours,Suzette Delaloge,David Gentien,Nicolas Servant,Brigitte Sigal-Zafrani,Fabrice Andre,Carmen Criscitiello,H.A. Azim,D. Agbor-Tarh,H. Eidtmann,S. Di Cosimo,I. Bradbury,I.T. Rubio,V. Semiglazov,B. Żurawski,R. Allerton,A. Fabi,E. Ciruelos,Roma Parikh,M. DeSilvio,S. Santillana,R. Swaby,S. Verma,David Miles,Ian E. Krop,M. Welslau,Mark D. Pegram,D-Y. Oh,Véronique Diéras,Ellie Guardino,L. Fang,M. Lu,S. Olsen,Kimberly L. Blackwell,T. Bachelot,M. Campone,M. Arnedos Ballester,Frédéric Commo,A. Gonçalves,C. Levy,J. Ferrero,Ludovic Lacroix,F. Dalenc,M. Lacroix,Q. Wang,J. Adelaide,M. Jimenez,C. Heery,Nuhad K. Ibrahim,R.A. Madan,M. Mohebtash,P. Arlen,S. McMahon,S. Hodge,S.M. Steinberg,J. Schlom,J.L. Gulley,B. Chauffert,L. Feuvret,F. Bonnetain,L. Taillandier,D. Frappaz,J. Honnorat,M. Fabbro,M. Frenay,X. Durando,I. Tennevet,J.S. Guillamo,H. Tailla,R. Schott,F. Ghiringhelli,C. Campello,C. Dalban,J. Skrzypski,O. Chinot,E. Tabouret,F. Boudouresque,M. Barrié,M. Matta,C. Boucard,A. Loundou,M. Ouafik,Y. Xu,M. Cardoso,M.O. Palumbo,O. Ishibashi,H. Oltean,K. Kumari,Petr Kavan,A. James,P. Mulholland,S. Peoples,O. Al-Salihi,Chris Twelves,S. Jefferies,S. Halford,J. Ritchie,H. Singh-Jasuja,R. Rampling,J. Taieb,J. Tabernero,Enrico Mini,F. Subtil,G. Folprecht,J.-L. Van Laethem,J. Thaler,J.A. Bridgewater,E. Van Cutsem,P. Rougier,Laurence Collette,M. Praet,M. Schneider,O. Bouché,C. Lepage,C. Girault,J.F. Emile,P. Laurent-Puig,L. Bedenne,G. Masi,F. Loupakis,L. Salvatore,C. Cremolini,L. Fornaro,M. Schirripa,E. Fea,C. Granetto,L. Antonuzzo,E. Giommoni,G. Allegrini,S. Cupini,C. Boni,M. Banzi,S. Chiara,C. Sonaglio,C. Valsuani,A. Bonetti,L. Boni,A. Falcone,A. Grothey,A. Sobrero,S. Siena,M. Ychou,Yves Humblet,L. Mineur,Carlo Barone,A. Adenis,T. Yoshino,H-J. Lenz,Richard M. Goldberg,Daniel J. Sargent,Frank Cihon,L. Cupit,Andrea Wagner,D. Laurent,Andrew X. Zhu,Olivier Rosmorduc,J. Evans,Paul Ross,A. Santoro,F.J. Carrilho,MA LeBerre,M. Jensen,Gerold Meinhardt,Y-K. Kang,F. Lordick,G. Bodoky,H.C. Chung,G. Kurteva,Sang Cheul Oh,P. Salman,H. Goette,H. Melezinkova,Markus Moehler,Kensaku Yoshida,Masashi Fujii,Wasaburou Koizumi,H. Kim,Yang Hyun Kim,Masahiro Takeuchi,T. Nakajima,David R. Ferry,Susan J Dutton,W. Mansoor,J. Thompson,M. Harrison,H. Abbas,A. Dahle-Smith,A. Chatterjee,S. Falk,A. Garcia-Alonso,D.W. Fyfe,R. Hubner,T. Gamble,L. Peachey,M. Davoudianfar,Sarah Pearson,Patrick Julier,Janusz Jankowski,R. Midgely,Russell D. Petty,Robert J. Motzer,Thomas E. Hutson,J. Reeves,Robert E. Hawkins,Jun Guo,Paul Nathan,Michael Staehler,P. de Souza,Jaime R. Merchan,K. Fife,Jie Jin,Robert Jones,Hirotsugu Uemura,U. De Giorgi,Ulrika Harmenberg,J. Wang,David Cella,Lauren McCann,Keith C. Deen,Toni K. Choueiri,Brian I. Rini,J. Bellmunt,J. Clancy,K. Wang,A. Niethammer,Bernard Escudier,T. Hutson,E. Esteban,G.A. Bjarnason,H. Y. Lim,K. Pittman,P. Senico,D. Lu,Subramanian Hariharan,R.J. Motzer,D. Olmos Hidalgo,D. Brewer,Gerhardt Attard,Daniel C. Danila,J. Clark,Chris Parker,Elena Castro,M. Fleischer,Alison Reid,Shahneen Sandhu,R.J. Jones,C.S. Cooper,Howard I. Scher,J.S. de Bono,Daniel P. Petrylak,Karim Fizazi,C.N. Sternberg,N. Budnik,R. de Wit,P.J. Wiechno,Debora Barton,A. Fandi,U. Jungnelius,S. Li,N. Vogelzang,Christophe Massard,Nicholas D. James,S. Culine,A. Vuorela,Mika Mustonen,A.M. Poveda,F. Selle,F. Hilpert,Alexander Reuss,A. Pasic,A. Savarese,Ignace Vergote,Petronella O. Witteveen,Aristotle Bamias,D. Bollag,Eric Pujade-Lauraine,D. Berton-Rigaud,J. Alexandre,M. Provansal,A. Casado,A. Gonzalez Martin,C. Fernández,C. Kahatt,S. Szyldergemajn,J. M. Del Campo,E.M. Guerra,I. Ray-Coquard,J. Balmana,N. Bosch,N. Gadea,C. Heredia,T. Olive,D. Valcárcel,M. Munill,C. Centeno,J.L. Quesada,J. Surralles,Georgina V. Long,J. A. Sosman,Adil Daud,J.S. Weber,Keith T. Flaherty,J. R. Infante,O. Hamid,Lynn M. Schuchter,Jonathan Cebon,Igor Puzanov,Alain Algazi,R. Kudchakar,Karl D. Lewis,W. Hwu,Richard F. Kefford,Peng Sun,Shonda M Little,Ricardo J. Gonzalez,Kiran Patel,K. B. Kim,A. Ribas,A.S. Daud,Anna C. Pavlick,Thomas F. Gajewski,M.S.L. Teng,I. Chan,Nicholas Choong,G. McArthur,Iben Spanggaard,M. Snoj,Andrea Cavalcanti,C. Bouquet,G. Sersa,C. Robert,B. Vasseur,P. Attali,Lluis M. Mir,Julie Gehl,Alice T. Shaw,Dong Wook Kim,Kazuhiko Nakagawa,T. Seto,L. Crinò,M-J. Ahn,T. De Pas,Benjamin Besse,Benjamin Solomon,F.H. Blackhall,Yi-Long Wu,Michael Thomas,Kenneth J. O'Byrne,D. Moro-Sibilot,R. Camidge,V. Tassell,Anna Polli,Pasi A. Jänne,J.G. Aerts,H. Codrington,S. Burgers,B. Biesma,O. Dalesio,A-M.C. Dingemans,A.D. Vincent,H.J.M. Groen,L.S. Schwartzberg,K. Tauer,J. Atkins,K. Sivarajan,V. Patel,Bruno R. Bastos,Corey J. Langer,Mark A. Socinski,David R. Spigel,R. Rosell,B. Massuti Sureda,C. Costa,M.A. Molina,A. Gimenez-Capitan,N. Karachaliou,J. Wei,A. Vergnenegre,P. Giannikopoulos,C. Mermel,Trever G. Bivona,F. De Marinis,Enriqueta Felip,T. Moran Bueno,R. Gervais,M. Santarpia,Margarita Majem,J. Bosch-Barrera,M.R. Garcia-Campelo,Lei Zhang,J.C-H. Yang,Heather A. Wakelee,T. Schmelter,Suresh S. Ramalingam,Jeffrey Crawford,A. Chang,C. Manegold,Roman Perez-Soler,J. Douillard,Nick Thatcher,F. Barlesi,Taofeek K. Owonikoko,Y. Wang,P. Pultar,J. Zhu,R. Malik,G. Giaccone,B. Zaric,G. Goss,V. Vukovic,I. El-Hariry,F. Teofilovici,A. Enke,D.A. Fennell,Nicole M. Kuderer,H. Wang,J. Mehta,L. Eckert,A. Hamed,Ramon Luengo-Fernandez,Jose Leal,Richard Sullivan,A. Mori,A. Goren,Isabelle Gilloteau,M.D. Dibonaventura,Arthur L. Klatsky,Yan Li,David Baer,Mary Anne Armstrong,Natalia Udaltsova,G.D. Friedman,S. Cushen,Aoife M. Ryan,L. Burns,U. Kenny,D.G. Power,Ian Judson,Jaap Verweij,Hans Gelderblom,J.T. Hartmann,Patrick Schöffski,J. Blay,A. P. Dei Tos,Sandrine Marreaud,Saskia Litière,W.T.A. van der Graaf,S. Lavau-Denes,P. Lacroix,A. Maubon,P. Preux,D. Genet,L. Venat-Bouvet,J. Labourey,J. Martin,P. Slaouti,L. Jia,Y. Lou,M. Liu,D. Wan,S. Zhu,H. Tan,L. Gissmann +521 more
TL;DR: Post-hoc analyses of efficacy outcomes in MISSION suggest that advanced NSCLC patients with EGFR mutations may derive a survival benefit from receiving 3rd/4th line sorafenib, and these results must be interpreted with caution due to the small, non-representative nature of the genetic biomarker subpopulation analyzed in this trial.
Journal ArticleDOI
Sorafenib (SOR) or placebo (PL) in combination with transarterial chemoembolization (TACE) for intermediate-stage hepatocellular carcinoma (SPACE).
Riccardo Lencioni,J. Zou,MA LeBerre,Gerold Meinhardt,D. Voliotis,Jordi Bruix,Josep M. Llovet +6 more
TL;DR: The phase II SPACE study is being conducted in North America, Europe, and the Asia-Pacific region to evaluate the efficacy and safety of TACE plus doxorubicin-eluting beads plus either SOR or PL in patients with intermediate-stage HCC.
Journal ArticleDOI
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer
José Baselga,Claudio Zamagni,Patricia Gomez,Begoña Bermejo,Shigenori E. Nagai,Bohuslav Melichar,Arlene Chan,László Mangel,Jonas Bergh,Frederico Costa,Henry L. Gomez,William J. Gradishar,Clifford A. Hudis,Bernardo Leon Rapoport,Henri Roché,Patricia Maeda,L. Huang,Gerold Meinhardt,Joshua Zhang,Lee S. Schwartzberg +19 more
TL;DR: The combination of sorafenib with capecitabine did not improve progression‐free survival, overall survival, or overall response rate, but increased treatment‐related toxicities and discontinuations in patients with advanced HER2‐negative breast cancer.
Journal ArticleDOI
Biomarker analyses of clinical outcomes in patients with advanced hepatocellular carcinoma treated with Sorafenib with or without Erlotinib in the SEARCH Trial
Andrew X. Zhu,Yoon-Koo Kang,Olivier Rosmorduc,T.R. Jeffry Evans,Armando Santoro,Paul Ross,E.J. Gane,Arndt Vogel,Michael Jeffers,Gerold Meinhardt,Carol Peña +10 more
TL;DR: Baseline plasma HGF, VEGFA, KIT, and VEGFC correlated with clinical outcomes in hepatocellular carcinoma patients treated with sorafenib with or without erlotinib, and these biomarkers plus EPGN constituted a multimarker signature for improved OS.
Journal ArticleDOI
Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials.
Alexandra Giatromanolaki,M I Koukourakis,Efthimios Sivridis,K C Gatter,Tanja Trarbach,Gunnar Folprecht,M. Shi,David Lebwohl,T Jalava,D Laurent,Gerold Meinhardt,Adrian L. Harris +11 more
TL;DR: Assessment of the activated vessel density may allow the stratification of patients recruited in randomised trials with VEGFR-targeting anti-angiogenic agents, unmasking their therapeutic potential and enabling their introduction in the clinical practice for the benefit of specific patient subgroups, at the same time reducing the cost of therapy.